Your browser doesn't support javascript.
loading
Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.
Nagata, Hiroaki; Kuriyama, Kodai; Nishikawa, Rina; Ohshiro, Muneo; Yamamoto-Sugitani, Mio; Fujimoto-Hirakawa, Yoshiko; Matsumoto, Yosuke; Iwai, Toshiki; Tsukamoto, Taku; Mizutani, Shinsuke; Shimura, Yuji; Kobayashi, Tsutomu; Fukuda, Wataru; Uchiyama, Hitoji; Kuroda, Junya.
Afiliação
  • Nagata H; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Kuriyama K; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Nishikawa R; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Ohshiro M; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Yamamoto-Sugitani M; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Fujimoto-Hirakawa Y; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Matsumoto Y; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Iwai T; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Tsukamoto T; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Mizutani S; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Shimura Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Kobayashi T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Fukuda W; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Uchiyama H; Center for Rheumatic Disease, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
  • Kuroda J; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Ann Hematol ; 100(11): 2849-2850, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34420071
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Metotrexato / Cromonas / Antirreumáticos / Imunossupressores / Transtornos Linfoproliferativos Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Metotrexato / Cromonas / Antirreumáticos / Imunossupressores / Transtornos Linfoproliferativos Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão